The combination of ceftolozane and tazobactam showed comparable outcomes to levofloxacin in the treatment of complicated pyelonephritis, according to results from the Phase 3 ASEPCT-cUTI trial presented at IDWeek 2015.
Live at IDWeek 2015
Administering diuretics does not increase acute kidney injury (AKI) risk among HIV-positive patients who are taking tenofovir disoproxil fumarate (TDF), and controlling blood pressure may be a more important consideration when it comes to preventing AKI, suggests a retrospective analysis reported at IDWeek 2015.
Neonatal acellular pertussis vaccination may be a safe alternative to maternal immunization, according to efficacy data presented at IDWeek 2015.
Introduction of early childhood immunization with the pneumococcal conjugate PCV13 vaccine has rapidly reduced the incidence of pediatric consolidated pneumonia (CP) cases in Argentina, according to findings from a prospective single-municipality population-based study reported at IDWeek 2015.
Due to several potential barriers, the rates of completion for the human papillomavirus (HPV) vaccine series are lower among HIV-positive patients and men at Denver Health, a large urban public healthcare system, researchers reported at IDWeek 2015.
Statins are associated with decreased progression of liver disease among patients who are coinfected with HIV and hepatitis C virus (HCV), according findings from a single-institution cohort study reported at IDWeek 2015.
Including tenofovir alafenamide (TAF) in single-tablet elvitegravir/cobicistat/emtricitabine (E/C/F/TAF) is associated with reduced renal and bone toxicity compared to tenofovir disoproxil fumarate (TDF)-containing single-tablet (E/C/F/TDF) therapy, according to an analysis of data from two Phase 3 trials, reported at IDWeek 2015.
Attenuated live rotavirus vaccine (RV5) appears to be safe and immunogenic among HIV-positive and HIV-exposed but uninfected (HEU) infants, according to findings from the randomized, double-blind, Phase 2 IMPAACT P1072 study reported at IDWeek 2015.
Dual therapy with vancomycin plus a beta-lactam antibiotic may reduce surgical site infections (SSI) by up to 63%, a study presented at IDWeek 2015 has found, with the strongest association seen in cardiac procedures.
Even though probiotics are frequently administered in pediatric intensive care units (ICUs), incidence of probiotic-associated bacteremia appears to be low, authors of a single-institution case-control study reported at IDWeek 2015.
Want to read more?
Please login or register first to view this content.